Neoadjuvant treatment before radical prostatectomy: Current situation
8 May 2019
Neoadjuvant treatment before radical prostatectomy: Current situation
Emerging management of metastatic castration-sensitive prostate cancer: front-line chemotherapy vs. oral therapy
Highlights from IGILUC 2019
How the WIN consortium achieves its goals
The translational element of the WIN consortium
Making oncology global with the WIN consortium
An overview of the WIN consortium
The WIN symposium 2019
Gynaecological cancer: Where are we now?
CB-839 in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer
ASCO GU 2019 renal highlights
ARCHES trial: Androgen deprivation therapy with enzalutamide or placebo in mHSPC